The Ultimate Vendor Audit SOP Every Pharma Professional Must Know

Vendor Audit SOP

Table of Contents

1. Purpose

To define a comprehensive, risk-based, and systematic procedure for the evaluation, qualification, approval, and continuous monitoring of vendors, ensuring that all materials and services procured consistently meet quality, safety, and regulatory requirements (GMP/GDP).

This SOP aims to:

  • Safeguard product quality and patient safety
  • Ensure regulatory compliance
  • Strengthen supply chain reliability
  • Promote continuous improvement

2. Scope

This SOP applies to all vendors supplying:

  • Active Pharmaceutical Ingredients (APIs)
  • Excipients
  • Primary and secondary packaging materials
  • Contract manufacturing organizations (CMOs)
  • Contract testing laboratories
  • Critical service providers (e.g., sterilization, calibration)

Applicable to all departments involved in vendor lifecycle management:

  • Quality Assurance (QA)
  • Quality Control (QC)
  • Procurement/Purchase
  • Regulatory Affairs (RA)
  • Warehouse

3. Responsibilities

3.1 Quality Assurance (QA)

  • Prepare and maintain vendor audit program
  • Perform risk assessment and vendor classification
  • Plan, conduct, and document audits
  • Review and approve CAPA
  • Finalize vendor approval/rejection
  • Maintain Approved Vendor List (AVL)

3.2 Procurement/Purchase

  • Identify potential vendors
  • Collect vendor documentation
  • Ensure procurement from approved vendors only
  • Communicate audit schedules with vendors

3.3 Quality Control (QC)

  • Evaluate material quality data
  • Provide analytical reports and trends
  • Support technical evaluation during audits

3.4 Regulatory Affairs (RA)

  • Verify compliance with regulatory requirements
  • Review vendor certifications and approvals

3.5 Warehouse

  • Ensure materials are received from approved vendors
  • Maintain traceability and storage compliance

3.6 Vendor

  • Provide complete and accurate documentation
  • Facilitate audit activities
  • Implement CAPA within defined timelines

4. Definitions

  • Vendor/Supplier: Entity supplying materials/services impacting product quality
  • Vendor Audit: Systematic evaluation of vendor’s compliance with GMP
  • Critical Vendor: Vendor directly impacting product quality (e.g., API supplier)
  • CAPA: Corrective and Preventive Action
  • AVL: Approved Vendor List
  • For-Cause Audit: Audit triggered by quality issues

5. Procedure

5.1 Vendor Lifecycle Overview

  1. Vendor Identification
  2. Pre-Qualification
  3. Risk Assessment
  4. Audit Planning
  5. Audit Execution
  6. CAPA Management
  7. Approval & Listing (AVL)
  8. Performance Monitoring
  9. Periodic Requalification

5.2 Vendor Classification (Risk-Based)

Vendors shall be classified based on risk to product quality:

CategoryExamplesAudit Requirement
CriticalAPI, sterile products, CMOsMandatory on-site audit
MajorExcipients, primary packagingAudit required
MinorSecondary packagingQuestionnaire-based

Risk Factors Considered:

  • Material criticality
  • Regulatory impact
  • Past performance
  • Supply chain complexity

5.3 Vendor Pre-Qualification

Step 1: Vendor Information Collection

Vendor shall submit:

  • Company profile
  • GMP certificate
  • Manufacturing license
  • Regulatory approvals
  • Product specifications
  • COA samples
  • Previous audit reports

Step 2: Vendor Questionnaire Review

QA evaluates:

  • Quality systems
  • Documentation practices
  • Infrastructure
  • Compliance history

Step 3: Risk Assessment

  • Assign risk rating (High/Medium/Low)
  • Decide audit type:
    • On-site
    • Remote
    • Paper-based

5.4 Audit Planning

  • Annual audit schedule prepared by QA
  • Audit plan includes:
    • Scope
    • Objectives
    • Audit team
    • Timeline

Audit Notification

  • Sent to vendor at least 2–4 weeks in advance
  • Includes agenda and document requirements

5.5 Audit Execution


5.5.1 Opening Meeting

  • Introduce audit team
  • Confirm audit scope
  • Review agenda

5.5.2 Detailed Audit Areas

A. Quality Management System (QMS)

  • SOP control
  • Deviation handling
  • Change control
  • CAPA effectiveness

B. Personnel & Training

  • Qualification
  • Training records
  • GMP awareness

C. Facilities & Equipment

  • Layout and design
  • Maintenance
  • Calibration

D. Production & Process Control

  • Process validation
  • In-process controls
  • Batch records

E. Quality Control

  • Testing methods
  • Stability studies
  • Laboratory controls

F. Material Management

  • Raw material control
  • Storage conditions
  • Traceability

G. Documentation Practices

  • Data recording
  • Record retention
  • Good Documentation Practices (GDP)

H. Data Integrity

  • ALCOA+ principles
  • Electronic system controls
  • Audit trails

I. Regulatory Compliance

  • GMP adherence
  • Inspection history
  • Licenses and certifications

5.5.3 Observation Classification

ClassificationDescription
CriticalDirect risk to patient safety
MajorSignificant GMP deviation
MinorLow-risk issue

5.5.4 Closing Meeting

  • Present observations
  • Discuss CAPA timelines
  • Obtain vendor agreement

5.6 Audit Reporting

  • Audit report issued within 15 working days
  • Report includes:
    • Summary
    • Detailed observations
    • Risk classification
    • CAPA requirements

5.7 CAPA Management

CAPA Submission

  • Vendor must submit within 15–30 days

QA Review

  • Evaluate:
    • Root cause
    • Corrective actions
    • Preventive measures

CAPA Approval

  • Accepted / Rejected / Requires revision

Follow-Up

  • Re-audit if required

5.8 Vendor Approval

StatusCriteria
ApprovedNo critical observations
ConditionalCAPA pending
RejectedMajor/critical non-compliance

Approved vendors are added to AVL.


5.9 Vendor Performance Monitoring

Continuous monitoring based on:

  • Material quality trends
  • Complaints
  • Deviation reports
  • On-time delivery

5.10 Vendor Requalification

Frequency

  • Critical: 1–2 years
  • Major: 2–3 years
  • Minor: As required

Triggers for Re-Audit

  • Quality issues
  • Regulatory findings
  • Change in process/location

5.11 For-Cause Audit

Triggered by:

  • OOS results
  • Product recalls
  • Customer complaints
  • Regulatory observations

5.12 Documentation & Record Control

Maintain:

  • Audit plans
  • Reports
  • CAPA records
  • Vendor documents

Retention Period: Minimum 5–10 years


6. Compliance & Risk Management

  • Follow GMP & GDP guidelines
  • Ensure data integrity (ALCOA+)
  • Apply risk-based decision-making
  • Promote continuous improvement

7. Key Performance Indicators (KPIs)

  • % vendors audited on schedule
  • CAPA closure time
  • Vendor rejection rate
  • Audit compliance score

8. Attachments / Templates

  • Vendor Questionnaire
  • Audit Checklist
  • Audit Report Template
  • CAPA Form
  • Approved Vendor List (AVL)

9. Abbreviations

  • GMP – Good Manufacturing Practices
  • GDP – Good Documentation Practices
  • CAPA – Corrective and Preventive Action
  • AVL – Approved Vendor List
  • QMS – Quality Management System


Here are 30 in-depth FAQs for Vendor Audit SOP, designed to be practical, interview-ready, and regulatory-focused:


📌 FAQs – Vendor Audit SOP


1. What is a vendor audit in the pharmaceutical industry?

A vendor audit is a systematic and independent evaluation of a supplier’s quality systems, manufacturing practices, and compliance with GMP requirements to ensure that materials/services meet predefined quality standards.


2. Why is vendor qualification mandatory before procurement?

It ensures that only reliable and compliant suppliers are used, reducing risks of:

  • Product contamination
  • Regulatory non-compliance
  • Batch failures

3. What are the different types of vendor audits?

  • On-site Audit – Physical inspection of facility
  • Remote Audit – Virtual/document-based
  • For-cause Audit – Triggered by issues
  • Routine Audit – Periodic re-evaluation

4. What is a risk-based approach in vendor audits?

It involves classifying vendors based on criticality and impact on product quality, ensuring high-risk vendors receive more stringent evaluation and frequent audits.


5. Who decides whether a vendor audit is required?

The Quality Assurance (QA) department decides based on:

  • Risk assessment
  • Material criticality
  • Regulatory requirements

6. What documents are reviewed before conducting an audit?

  • GMP certificates
  • Quality manual
  • Product specifications
  • COA (Certificate of Analysis)
  • Previous audit reports

7. What is a vendor questionnaire?

A structured document used for preliminary evaluation of a vendor’s:

  • Quality system
  • Infrastructure
  • Regulatory compliance

8. What is the purpose of an opening meeting during an audit?

To:

  • Define audit scope
  • Introduce audit team
  • Align expectations with vendor

9. What areas are covered during a vendor audit?

  • Quality Management System (QMS)
  • Production processes
  • Quality Control
  • Warehousing & distribution
  • Documentation practices
  • Data integrity

10. What is the importance of data integrity in vendor audits?

It ensures that all records are accurate, reliable, and trustworthy, following ALCOA+ principles, which is critical for regulatory compliance.


11. How are audit observations classified?

  • Critical: High risk to patient safety
  • Major: Significant deviation from GMP
  • Minor: Low-risk non-compliance

12. What is a critical observation?

A deficiency that directly impacts:

  • Product quality
  • Patient safety
  • Regulatory compliance

Example: Lack of validated manufacturing process.


13. What is a CAPA in vendor audits?

CAPA stands for Corrective and Preventive Action, addressing:

  • Root cause of deviation
  • Measures to prevent recurrence

14. What is root cause analysis in CAPA?

It identifies the underlying reason for a problem using tools like:

  • Fishbone diagram
  • 5 Why analysis

15. What is the typical timeline for CAPA submission?

Usually within 15–30 days after receiving the audit report.


16. What happens if CAPA is not satisfactory?

  • Re-submission is required
  • Vendor may be downgraded or rejected
  • Follow-up audit may be conducted

17. What is the Approved Vendor List (AVL)?

A controlled list of qualified and approved vendors authorized for procurement.


18. Can procurement be done from a non-approved vendor?

Generally not allowed, except in emergencies with:

  • QA approval
  • Temporary qualification

19. What is vendor requalification?

Periodic reassessment to ensure vendors continue to meet quality and regulatory standards.


20. How often should vendors be audited?

  • Critical vendors: Every 1–2 years
  • Major vendors: Every 2–3 years
  • Minor vendors: As needed

21. What triggers a for-cause audit?

  • Product complaints
  • OOS (Out of Specification) results
  • Regulatory findings
  • Supply chain issues

22. What is a remote audit and when is it used?

A virtual audit using:

  • Video conferencing
  • Document sharing

Used when:

  • Travel is restricted
  • Vendor risk is low

23. What is a vendor audit checklist?

A structured tool ensuring consistent and comprehensive evaluation of all audit areas.


24. What is the role of procurement during audits?

  • Coordinate with vendors
  • Share vendor details with QA
  • Ensure sourcing from approved vendors

25. What is the significance of COA verification?

It confirms that:

  • Test results are accurate
  • Materials meet specifications

26. What are common deficiencies observed during audits?

  • Poor documentation practices
  • Inadequate training records
  • Lack of validation
  • Data integrity issues

27. What is vendor performance monitoring?

Ongoing evaluation based on:

  • Quality trends
  • Delivery performance
  • Complaints

28. What is a technical agreement with vendors?

A formal document defining:

  • Responsibilities
  • Quality expectations
  • Regulatory obligations

29. What is the role of QA in vendor approval?

QA:

  • Conducts audits
  • Reviews CAPA
  • Grants final approval

30. How does vendor auditing impact regulatory inspections?

Strong vendor audit systems:

  • Demonstrate compliance
  • Reduce regulatory risks
  • Improve inspection outcomes (e.g., USFDA, MHRA)

For more articles, Kindly Click here

For pharmaceutical jobs, follow us on LinkedIn 

For Editable SOPs in Word format contact us on info@pharmaceuticalcarrier.com 

For more information kindly follow us on www.pharmaguidelines.co.uk

Leave a Comment

Your email address will not be published. Required fields are marked *